{"url_path":"/sec/cik-0001661306/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities and Use of Proceeds","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1661306/0001661306-26-000036-index.html","accession_number":"0001661306-26-000036","cik":"0001661306","ticker":null,"issuer_name":"Hancock Park Corporate Income, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1661306/0001661306-26-000036-index.html","primary_entity_key":"0001661306","primary_entity_name":"Hancock Park Corporate Income, Inc."},"word_count":480,"has_tables":true,"body_markdown":"Item 2. Unregistered Sales of Equity Securities and Use of Proceeds\n\nSales of Unregistered Securities, Use of Proceeds\n\nDuring the three months ended March 31, 2026, we did not sell any shares of our common stock.\n\nBecause shares of our common stock have been acquired by investors in one or more transactions “not involving a public offering”, they are “restricted securities” and may be required to be held indefinitely. Our common stock may not be sold, transferred, assigned, pledged or otherwise disposed of unless: (i) the transferor provides OFS Advisor with at least 10 days written notice of the transfer; (ii) the transfer is made in accordance with applicable securities laws; and (iii) the transferee agrees in writing to be bound by these restrictions and the other restrictions imposed on the common stock and to execute such other instruments or certifications as are reasonably required by us. Accordingly, an investor must be willing to bear the economic risk of investment in the common stock until we are liquidated. No sale, transfer, assignment, pledge or other disposition, whether voluntary or involuntary, of the common shares may be made except by registration of the transfer on our books.\n\nIssuer Purchases of Equity Securities\n\nSince November 2018, the Board has approved quarterly tender offers to purchase shares of our outstanding common stock. For the period from November 2019 through December 31, 2025, we conducted quarterly tender offers to purchase, in each case, 2.5% of the weighted average number of shares of the outstanding common stock for the trailing 12-month period. Commencing with the tender offer in March 2026, the Board expects to approve offers to purchase approximately 4.0% of the weighted average number of outstanding shares of our common stock in any 12-month period, subject to a 1.0% limit in each quarter. The offer to repurchase shares allows our stockholders to sell their shares back to us at a price equal to the most recently determined NAV per share of our common stock immediately prior to the date of repurchase. Any future decision to repurchase shares will be evaluated by the Board based on a variety of factors, including available liquidity, leverage considerations and investment opportunities. Our Board has the right to modify, suspend or terminate the share repurchase program at any time in its discretion if it determines that doing so is in our best interests.\n\nDuring the three months ended March 31, 2026, the Board approved an offer to purchase approximately 1.0% of the weighted average number of outstanding shares of our common stock. The following table summarizes the common stock repurchases by us for the three months ended March 31, 2026:\n\nThree Months Ended March 31, 2026\n\n \n\nNumber of Shares\n\n \n\n \n\nAmount\n\n \n\nJanuary 1, 2026 through January 31, 2026\n\n \n\n \n\n—\n\n \n\n \n\n$\n\n—\n\n \n\nFebruary 1, 2026 through February 28, 2026\n\n \n\n \n\n—\n\n \n\n \n\n \n\n—\n\n \n\nMarch 1, 2026 through March 31, 2026\n\n \n\n \n\n16,099\n\n \n\n \n\n \n\n115,425\n\n \n\n \n\n50"}